# Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

> **NCT01138579** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Technical University of Munich**

## Conditions studied

- Leukemia
- Stem Cell Transplantation

## Interventions

- **DRUG:** FBTA05

## Key facts

- **NCT ID:** NCT01138579
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Recruitment delayed, trial medication no loner available
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01138579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01138579, "Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01138579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*